174 related articles for article (PubMed ID: 25276822)
21. Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate.
Kleski KA; Trabbic KR; Shi M; Bourgault JP; Andreana PR
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183149
[TBL] [Abstract][Full Text] [Related]
22. Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
Heimburg-Molinaro J; Almogren A; Morey S; Glinskii OV; Roy R; Wilding GE; Cheng RP; Glinsky VV; Rittenhouse-Olson K
Neoplasia; 2009 Aug; 11(8):780-92. PubMed ID: 19649208
[TBL] [Abstract][Full Text] [Related]
23. Colon carcinoma glycoproteins carrying alpha 2,6-linked sialic acid reactive with Sambucus nigra agglutinin are not constitutively expressed in normal human colon mucosa and are distinct from sialyl-Tn antigen.
Murayama T; Zuber C; Seelentag WK; Li WP; Kemmner W; Heitz PU; Roth J
Int J Cancer; 1997 Mar; 70(5):575-81. PubMed ID: 9052758
[TBL] [Abstract][Full Text] [Related]
24. Quantitative lectin-histochemical and immunohistochemical studies on the occurrence of alpha(2,3)- and alpha(2,6)-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features.
Vierbuchen MJ; Fruechtnicht W; Brackrock S; Krause KT; Zienkiewicz TJ
Cancer; 1995 Sep; 76(5):727-35. PubMed ID: 8625173
[TBL] [Abstract][Full Text] [Related]
25. Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals.
Klaamas K; Kurtenkov O; Rittenhouse-Olson K; Brjalin V; Miljukhina L; Shljapnikova L; Engstrand L
Immunol Invest; 2002; 31(3-4):191-204. PubMed ID: 12472179
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Sommer H; Friese K
Histochem Cell Biol; 2005 Jun; 123(6):631-7. PubMed ID: 15889266
[TBL] [Abstract][Full Text] [Related]
27. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
28. Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis.
Shah MH; Telang SD; Shah PM; Patel PS
Glycoconj J; 2008 Apr; 25(3):279-90. PubMed ID: 18158621
[TBL] [Abstract][Full Text] [Related]
29. Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential.
Kurtenkov O
Biomed Res Int; 2020; 2020():9747040. PubMed ID: 32280709
[TBL] [Abstract][Full Text] [Related]
30. Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.
Xu PC; Gou SJ; Yang XW; Cui Z; Jia XY; Chen M; Zhao MH
BMC Immunol; 2012 Mar; 13():10. PubMed ID: 22404873
[TBL] [Abstract][Full Text] [Related]
31. Anti-Thomsen-Friedenreich (T) antibody-based ELISA and its application to human breast carcinoma detection.
Desai PR; Ujjainwala LH; Carlstedt SC; Springer GF
J Immunol Methods; 1995 Dec; 188(2):175-85. PubMed ID: 8551046
[TBL] [Abstract][Full Text] [Related]
32. Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study.
Cao Y; Stosiek P; Springer GF; Karsten U
Histochem Cell Biol; 1996 Aug; 106(2):197-207. PubMed ID: 8877380
[TBL] [Abstract][Full Text] [Related]
33. Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6.
Ulsemer P; Henderson G; Toutounian K; Löffler A; Schmidt J; Karsten U; Blaut M; Goletz S
Cancer Immunol Immunother; 2013 May; 62(5):875-87. PubMed ID: 23381581
[TBL] [Abstract][Full Text] [Related]
34. Association of Helicobacter pylori gastric infection with the suppressed Thomsen-Friedenreich antigen natural humoral response.
Kurtenkov O; Wadström T; Klaamas K; Vorobjova T; Uibo R
Scand J Gastroenterol; 1995 Feb; 30(2):116-21. PubMed ID: 7732332
[TBL] [Abstract][Full Text] [Related]
35. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
[TBL] [Abstract][Full Text] [Related]
36. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
Baldus SE; Zirbes TK; Hanisch FG; Kunze D; Shafizadeh ST; Nolden S; Mönig SP; Schneider PM; Karsten U; Thiele J; Hölscher AH; Dienes HP
Cancer; 2000 Apr; 88(7):1536-43. PubMed ID: 10738210
[TBL] [Abstract][Full Text] [Related]
37. Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy.
Almogren A; Abdullah J; Ghapure K; Ferguson K; Glinsky VV; Rittenhouse-Olson K
Front Biosci (Schol Ed); 2012 Jan; 4(3):840-63. PubMed ID: 22202095
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of thomsen-friedenreich-specific antibodies from human serum.
Butschak G; Karsten U
Tumour Biol; 2002; 23(3):113-22. PubMed ID: 12218291
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
[TBL] [Abstract][Full Text] [Related]
40. Glycoprofiling as a novel tool in serological assays of systemic sclerosis: a comparative study with three bioanalytical methods.
Klukova L; Bertok T; Petrikova M; Sediva A; Mislovicova D; Katrlik J; Vikartovska A; Filip J; Kasak P; Andicsová-Eckstein A; Mosnáček J; Lukáč J; Rovenský J; Imrich R; Tkac J
Anal Chim Acta; 2015 Jan; 853():555-562. PubMed ID: 25467503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]